tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Compare Royalty Pharma (RPRX) vs. Competitors

1,302 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Royalty Pharma
$47.90
$27.63B
21.65
55.27%
7 Buy
1 Hold
0 Sell
Strong Buy
Incyte
$95.89
$19.08B
14.98
68.32%
8 Buy
8 Hold
1 Sell
Moderate Buy
United Therapeutics
$581.69
$25.49B
16.17
107.98%
9 Buy
4 Hold
0 Sell
Moderate Buy
Ascendis Pharma
$233.20
$14.31B
-50.22
69.71%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.40
$17.20B
19.86
57.95%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$92.08
$23.14B
-17.95
6.27%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RPRX
Royalty Pharma
47.90
16.38
51.97%
INCY
Incyte
95.89
37.03
62.91%
UTHR
United Therapeutics
581.69
288.91
98.68%
ASND
Ascendis Pharma
233.20
95.36
69.18%
GMAB
Genmab
28.40
9.57
50.82%
BNTX
BioNTech SE
92.08
-2.06
-2.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts